ACCIÓ has awarded the TBDO with two VALUNI 2016 grants for technology transfer projects. The grants will help financing:

1. The incorporation of Microomics, a CRG spin-off that will offer professional services in the field of metagenomics analysis;
2. The licensing of a novel technology for the treatment of Huntington’s disease by means of CRG proprietary and patented Zinc Finger Proteins.